Cargando…
Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study
OBJECTIVES: To assess the performance of statistical methods used to compare the effectiveness between drugs in an observational setting in the presence of attrition. METHODS: In this simulation study, we compared the estimations of low disease activity (LDA) at 1 year produced by complete case anal...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995805/ https://www.ncbi.nlm.nih.gov/pubmed/35027398 http://dx.doi.org/10.1136/annrheumdis-2021-221477 |
_version_ | 1784684361610690560 |
---|---|
author | Mongin, Denis Lauper, Kim Finckh, Axel Frisell, Thomas Courvoisier, Delphine Sophie |
author_facet | Mongin, Denis Lauper, Kim Finckh, Axel Frisell, Thomas Courvoisier, Delphine Sophie |
author_sort | Mongin, Denis |
collection | PubMed |
description | OBJECTIVES: To assess the performance of statistical methods used to compare the effectiveness between drugs in an observational setting in the presence of attrition. METHODS: In this simulation study, we compared the estimations of low disease activity (LDA) at 1 year produced by complete case analysis (CC), last observation carried forward (LOCF), LUNDEX, non-responder imputation (NRI), inverse probability weighting (IPW) and multiple imputations of the outcome. All methods were adjusted for confounders. The reasons to stop the treatments were included in the multiple imputation method (confounder-adjusted response rate with attrition correction, CARRAC) and were either included (IPW2) or not (IPW1) in the IPW method. A realistic simulation data set was generated from a real-world data collection. The amount of missing data caused by attrition and its dependence on the ‘true’ value of the data missing were varied to assess the robustness of each method to these changes. RESULTS: LUNDEX and NRI strongly underestimated the absolute LDA difference between two treatments, and their estimates were highly sensitive to the amount of attrition. IPW1 and CC overestimated the absolute LDA difference between the two treatments and the overestimation increased with increasing attrition or when missingness depended on disease activity at 1 year. IPW2 and CARRAC produced unbiased estimations, but IPW2 had a greater sensitivity to the missing pattern of data and the amount of attrition than CARRAC. CONCLUSIONS: Only multiple imputation and IPW2, which considered both confounding and treatment cessation reasons, produced accurate comparative effectiveness estimates. |
format | Online Article Text |
id | pubmed-8995805 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-89958052022-04-27 Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study Mongin, Denis Lauper, Kim Finckh, Axel Frisell, Thomas Courvoisier, Delphine Sophie Ann Rheum Dis Epidemiology OBJECTIVES: To assess the performance of statistical methods used to compare the effectiveness between drugs in an observational setting in the presence of attrition. METHODS: In this simulation study, we compared the estimations of low disease activity (LDA) at 1 year produced by complete case analysis (CC), last observation carried forward (LOCF), LUNDEX, non-responder imputation (NRI), inverse probability weighting (IPW) and multiple imputations of the outcome. All methods were adjusted for confounders. The reasons to stop the treatments were included in the multiple imputation method (confounder-adjusted response rate with attrition correction, CARRAC) and were either included (IPW2) or not (IPW1) in the IPW method. A realistic simulation data set was generated from a real-world data collection. The amount of missing data caused by attrition and its dependence on the ‘true’ value of the data missing were varied to assess the robustness of each method to these changes. RESULTS: LUNDEX and NRI strongly underestimated the absolute LDA difference between two treatments, and their estimates were highly sensitive to the amount of attrition. IPW1 and CC overestimated the absolute LDA difference between the two treatments and the overestimation increased with increasing attrition or when missingness depended on disease activity at 1 year. IPW2 and CARRAC produced unbiased estimations, but IPW2 had a greater sensitivity to the missing pattern of data and the amount of attrition than CARRAC. CONCLUSIONS: Only multiple imputation and IPW2, which considered both confounding and treatment cessation reasons, produced accurate comparative effectiveness estimates. BMJ Publishing Group 2022-05 2022-01-13 /pmc/articles/PMC8995805/ /pubmed/35027398 http://dx.doi.org/10.1136/annrheumdis-2021-221477 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Epidemiology Mongin, Denis Lauper, Kim Finckh, Axel Frisell, Thomas Courvoisier, Delphine Sophie Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study |
title | Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study |
title_full | Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study |
title_fullStr | Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study |
title_full_unstemmed | Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study |
title_short | Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study |
title_sort | accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995805/ https://www.ncbi.nlm.nih.gov/pubmed/35027398 http://dx.doi.org/10.1136/annrheumdis-2021-221477 |
work_keys_str_mv | AT mongindenis accountingformissingdatacausedbydrugcessationinobservationalcomparativeeffectivenessresearchasimulationstudy AT lauperkim accountingformissingdatacausedbydrugcessationinobservationalcomparativeeffectivenessresearchasimulationstudy AT finckhaxel accountingformissingdatacausedbydrugcessationinobservationalcomparativeeffectivenessresearchasimulationstudy AT frisellthomas accountingformissingdatacausedbydrugcessationinobservationalcomparativeeffectivenessresearchasimulationstudy AT courvoisierdelphinesophie accountingformissingdatacausedbydrugcessationinobservationalcomparativeeffectivenessresearchasimulationstudy |